Faiez M. Zannad

Institution information unavailable

Research Areas

Discover Papers by Faiez M. Zannad

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

156

Publications

2071

Citations

193601

i10-index

1011

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
2013 ESH/ESC Guidelines for the management of arte...	2013	13664
The Effect of Spironolactone on Morbidity and Mort...	1999	9195
European Guidelines on cardiovascular disease prev...	2012	8493
ESC Guidelines for the diagnosis and treatment of ...	2012	6907
Global, regional, and national life expectancy, al...	2016	6601
2013 ESH/ESC Guidelines for the management of arte...	2013	5673
Cardiovascular and Renal Outcomes with Empaglifloz...	2020	5177
Eplerenone, a Selective Aldosterone Blocker, in Pa...	2003	4961
Empagliflozin in Heart Failure with a Preserved Ej...	2021	4828
2015 ESC Guidelines for the management of patients...	2015	3917

Publications

1.
2013 ESH/ESC Guidelines for the management of arterial hypertension
Year: 2013Citations: 13664DOI: 10.1093/eurheartj/eht151
2.
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Year: 1999Citations: 9195DOI: 10.1056/nejm199909023411001
3.
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Year: 2012Citations: 8493DOI: 10.1093/eurheartj/ehs092
4.
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Year: 2012Citations: 6907DOI: 10.1093/eurheartj/ehs104
5.
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
Year: 2016Citations: 6601DOI: 10.1016/s0140-6736(16)31012-1
6.
2013 ESH/ESC Guidelines for the management of arterial hypertension
Year: 2013Citations: 5673DOI: 10.1097/01.hjh.0000431740.32696.cc
7.
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Year: 2020Citations: 5177DOI: 10.1056/nejmoa2022190
8.
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
Year: 2003Citations: 4961DOI: 10.1056/nejmoa030207
9.
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Year: 2021Citations: 4828DOI: 10.1056/nejmoa2107038
10.
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Year: 2015Citations: 3917DOI: 10.1093/eurheartj/ehv316

About Faiez M. Zannad

Faiez M. Zannad is a researcher with 2071 publications and 193601 citations. Their research focuses on . With an h-index of 156, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Faiez M. Zannad and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year